Translocation of the cytoplasmic domain of ADAM13 to the nucleus is essential for Calpain8-a expression and cranial neural crest cell migration - PubMed (original) (raw)
Translocation of the cytoplasmic domain of ADAM13 to the nucleus is essential for Calpain8-a expression and cranial neural crest cell migration
Hélène Cousin et al. Dev Cell. 2011.
Abstract
ADAMs are transmembrane metalloproteases that control cell behavior by cleaving both cell adhesion and signaling molecules. The cytoplasmic domain of ADAMs can regulate the proteolytic activity by controlling the subcellular localization and/or the activation of the protease domain. Here, we show that the cytoplasmic domain of ADAM13 is cleaved and translocates into the nucleus. Preventing this translocation renders the protein incapable of promoting cranial neural crest (CNC) cell migration in vivo, without affecting its proteolytic activity. In addition, the cytoplasmic domain of ADAM13 regulates the expression of multiple genes in CNC, including the protease Calpain8-a. Restoring the expression of Calpain8-a is sufficient to rescue CNC migration in the absence of the ADAM13 cytoplasmic domain. This study shows that the cytoplasmic domain of ADAM metalloproteases can perform essential functions in the nucleus of cells and may contribute substantially to the overall function of the protein.
Copyright © 2011 Elsevier Inc. All rights reserved.
Figures
Figure 1. ADAM13 and 19 cooperate during CNC migration
A) Schematic representation of the graft. Donor embryos are injected in one cell at the 2-cell stage with GFP, or combinations of GFP, MO against ADAM13 and 19 and mRNA encoding various ADAM constructs. At stage 15, CNC are dissected and grafted into host embryos. CNC migration is visualized using a fluorescent microscope. B) Fluorescence photographs of representative grafted embryos at stage 24. A positive migration is only counted if cells have progressed ventrally in one or more of the posterior arches. C) Histogram representing the analysis of CNC migration in at least 3 independent experiments. The error bars correspond to the standard deviation (SD). N: number of embryos.
Figure 2. ADAM13 cytoplasmic domain translocates to the nucleus
A) Schematic representation of ADAM13 proteolytic processing (left). The Pro-domain is cleaved during transit to the cell surface (1). A second extracellular cleavage within the cysteine-rich domain has also been documented (2), releasing the active protease. The cytoplasmic domain is cleaved by GS (3). The GFP-fusion protein corresponding to the ADAM13 cytoplasmic domain and the various mutants are represented (right). B) Western blot of ADAM13 cytoplasmic domain. 293T Cells were transfected with GFP, GFP-C13, and wild-type ADAM13 (A13). Cells were fractionated to generate a cytoplasmic (C) and a nuclear (N) fraction. Fractions were analyzed by western blot using a polyclonal antibody to the cytoplasmic domain of ADAM13 (arrowhead) (Alfandari et al., 1997). All membrane-bound fragments of ADAM13 are found both in the cytoplasmic fraction (plasma membrane) and in the nuclear fraction (ER attached to the nuclear membrane). The nuclear proteins PARP is found in the nuclear fraction, while GAPDH is in the cytoplasm. C) ADAM13 was immunoprecipitated from 10 embryos using a goat polyclonal antibody. Non-injected embryos (NI) at stage 12 (gastrula) and stage 18 (neurula) are compared to sibling embryos injected with MO13. The ADAM13 protein was detected using 6615F. D) Cos-7 cells transfected with ADAM13 were treated for 4 hours with GS inhibitors (+, ILCHO 50 μM or DAPT 10 μM). E) Localization of GFP-fusion proteins expressed in XTC cells. Hoecht was used to detect the nuclei in cells transfected with GFP-C13NES. See also figure S2.
Figure 3. ADAM13 cytoplasmic domain is critical for cranial neural crest cell migration
A) Lateral view of representative embryos injected with RFP and a control MO (CMO) or with MO13 (see also Fig.S4). The white arrows point to the fluorescence observed in the three main CNC segments (from left to right, Mandibular Branchial and Hyoid). B) Histogram representing the percentage of embryos in which CNC migration was inhibited by either MO13 (black bars) or MO13 and MO19 (2MO, grey bars). The numbers on the right indicate the number of embryos scored for each construct (schematic representation to the left). Statistical significance (at least 3 independent experiments) was calculated using a student t test p<0.05. Significant rescue is indicated with an asterisk (*), error bars are SD. C) Western Blot from Cos-7 cells transfected with various ADAM13 constructs and the protocadherin PAPC. The cell extract (Cell) and the glycoprotein purified from the culture supernatant (Media) were probed with an antibody to the extracellular domain of PAPC. The cell extract was also probed with the 7C9, a monoclonal antibody to the cysteine-rich domain of ADAM13. D) Fluorescence images of live XTC cells transfected with GFP-fusion proteins corresponding to the various ADAM cytoplasmic domains. The ADAM number and the species are indicated (xl; Xenopus laevis, dr; Danio rerio, mm; mus musculus). E) Histogram representing the rescue experiments described in (A), using a complementation assay. The total number of embryos scored in at least 3 independent experiments is indicated on the right (N). Asterisk indicate significant rescue (p<0.05), error bars are SD. The species name is indicated according to standard nomenclature (ce; Caenorhadbitis elegans, md; Monodelphis domestica).
Figure 4. The cytoplasmic domain of ADAM13 regulates gene expression
A) Representative genes were selected from the microarray data. The average fold change between the control MO and MO13 (MO13) or between MO13 and the rescue MO13 plus GFP-C13 (MO13+C13) is represented as a Log2. Error bars represent the SD. Four groups of genes are presented. Xmc (Xenopus Marginal Coil), Pafr (Platelet-activating factor receptor), capn8-a (Calpain8-a), Wnt3-A (Wingless-type MMTV integration site 3A) and Pou50 (Pou-homeobox gene 50) are decreased in CNC injected with MO13 and are partially rescued by GFP-C13. Nudc (Nuclear distribution gene C), Rad1 (Cell cycle check point) and Vamp8 (Vesicle-associated membrane protein 8) are increased in CNC lacking ADAM13, and rescued by GFP-C13. Dusp18 (Dual specificity Phosphatase 18) and mek-2 (Erk Kinase) are increased in CNC with MO13, while camK1 (Calcium/calmodulin-dependent protein kinase 1) and Dap (Death-associated protein kinase 1) are decreased, with no significant effect from GFP-C13. B) Histogram representation of quantitative PCR data. Amplification was performed from cDNA isolated from CNC of embryos injected with either MO13 or a combination of MO13, plus the cytoplasmic domains of ADAM9 (blue), ADAM13 (red) or ADAM19 (green). Values are represented as the Log2 fold change compared to MO13 alone. Error bars correspond to the SD between triplicates. (Myt1: myelin transcription factor 1, Fst: follistatin, Nubp1: nucleotide binding protein 1, Inta6: Integrin alpha 6). C) Complementation assays with embryos injected with MO13 plus ΔCyto alone or with either MMP13, Capn8-a or Xmc. CNC migration was also measured in embryos injected with a MO to Capn8-a or a DN Capn8-a construct (Capn8-aC105S). The total number of embryos is given (n). Error bars correspond to the SD. Statistical analysis was done using a student t test. Asterisk represents p values <0.01, for a or <0.05 for b. Representative examples are given in D.
Similar articles
- GSK3 and Polo-like kinase regulate ADAM13 function during cranial neural crest cell migration.
Abbruzzese G, Cousin H, Salicioni AM, Alfandari D. Abbruzzese G, et al. Mol Biol Cell. 2014 Dec 15;25(25):4072-82. doi: 10.1091/mbc.E14-05-0970. Epub 2014 Oct 8. Mol Biol Cell. 2014. PMID: 25298404 Free PMC article. - ADAM13 function is required in the 3 dimensional context of the embryo during cranial neural crest cell migration in Xenopus laevis.
Cousin H, Abbruzzese G, McCusker C, Alfandari D. Cousin H, et al. Dev Biol. 2012 Aug 15;368(2):335-44. doi: 10.1016/j.ydbio.2012.05.036. Epub 2012 Jun 7. Dev Biol. 2012. PMID: 22683825 Free PMC article. - The Wnt receptor Frizzled-4 modulates ADAM13 metalloprotease activity.
Abbruzzese G, Gorny AK, Kaufmann LT, Cousin H, Kleino I, Steinbeisser H, Alfandari D. Abbruzzese G, et al. J Cell Sci. 2015 Mar 15;128(6):1139-49. doi: 10.1242/jcs.163063. Epub 2015 Jan 22. J Cell Sci. 2015. PMID: 25616895 Free PMC article. - Cut loose and run: The complex role of ADAM proteases during neural crest cell development.
Alfandari D, Taneyhill LA. Alfandari D, et al. Genesis. 2018 Jun;56(6-7):e23095. doi: 10.1002/dvg.23095. Epub 2018 Feb 24. Genesis. 2018. PMID: 29476604 Free PMC article. Review. - Mechanism of Xenopus cranial neural crest cell migration.
Alfandari D, Cousin H, Marsden M. Alfandari D, et al. Cell Adh Migr. 2010 Oct-Dec;4(4):553-60. doi: 10.4161/cam.4.4.12202. Epub 2010 Oct 1. Cell Adh Migr. 2010. PMID: 20505318 Free PMC article. Review.
Cited by
- Genetic requirement of dact1/2 to regulate noncanonical Wnt signaling and calpain 8 during embryonic convergent extension and craniofacial morphogenesis.
Carroll SH, Schafer S, Kawasaki K, Tsimbal C, Julé AM, Hallett SA, Li E, Liao EC. Carroll SH, et al. bioRxiv [Preprint]. 2024 Sep 4:2023.11.07.566024. doi: 10.1101/2023.11.07.566024. bioRxiv. 2024. PMID: 37986847 Free PMC article. Preprint. - ADAM11 a novel regulator of Wnt and BMP4 signaling in neural crest and cancer.
Pandey A, Cousin H, Horr B, Alfandari D. Pandey A, et al. Front Cell Dev Biol. 2023 Sep 12;11:1271178. doi: 10.3389/fcell.2023.1271178. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37766964 Free PMC article. - Production and characterization of monoclonal antibodies to Xenopus proteins.
Horr B, Kurtz R, Pandey A, Hoffstrom BG, Schock E, LaBonne C, Alfandari D. Horr B, et al. Development. 2023 Feb 15;150(4):dev201309. doi: 10.1242/dev.201309. Epub 2023 Feb 15. Development. 2023. PMID: 36789951 Free PMC article. - An unexpected role for the conserved ADAM-family metalloprotease ADM-2 in Caenorhabditis elegans molting.
Joseph BB, Edeen PT, Meadows S, Binti S, Fay DS. Joseph BB, et al. PLoS Genet. 2022 May 31;18(5):e1010249. doi: 10.1371/journal.pgen.1010249. eCollection 2022 May. PLoS Genet. 2022. PMID: 35639786 Free PMC article. - Notch signaling pathway: architecture, disease, and therapeutics.
Zhou B, Lin W, Long Y, Yang Y, Zhang H, Wu K, Chu Q. Zhou B, et al. Signal Transduct Target Ther. 2022 Mar 24;7(1):95. doi: 10.1038/s41392-022-00934-y. Signal Transduct Target Ther. 2022. PMID: 35332121 Free PMC article. Review.
References
- Abe K, Takeichi M. NMDA-receptor activation induces calpain-mediated beta-catenin cleavages for triggering gene expression. Neuron. 2007;53:387–397. - PubMed
- Alfandari D, Cousin H, Gaultier A, Smith K, White JM, Darribere T, DeSimone DW. Xenopus ADAM 13 is a metalloprotease required for cranial neural crest- cell migration. Curr Biol. 2001;11:918–930. - PubMed
- Alfandari D, Wolfsberg TG, White JM, DeSimone DW. ADAM 13: a novel ADAM expressed in somitic mesoderm and neural crest cells during Xenopus laevis development. Dev Biol. 1997;182:314–330. - PubMed
- Blobel CP. ADAMs: key components in EGFR signalling and development. Nat Rev Mol Cell Biol. 2005;6:32–43. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 DE016289-03/DE/NIDCR NIH HHS/United States
- R01 DE016289-01A2/DE/NIDCR NIH HHS/United States
- R01 DE016289-02/DE/NIDCR NIH HHS/United States
- R01 DE016289-05/DE/NIDCR NIH HHS/United States
- R01 DE016289/DE/NIDCR NIH HHS/United States
- R01 DE016289-04/DE/NIDCR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous